ArticleCureus2025
Primary Gastrointestinal Stromal Tumor of the Pancreatic Head: A Diagnostic Challenge Mimicking a Neuroendocrine Tumor.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic hypervascular masses can be difficult to characterize on cross-sectional imaging, particularly when different entities share similar enhancement patterns. We report the case of a 63-year-old woman with a three-month history of abdominal pain and progressive distension. Contrast-enhanced computed tomography (CT) revealed a 49 × 60 mm irregular hypervascular mass in the pancreatic head with peripheral arterial-phase enhancement, a large central low-attenuation area compatible with necrosis, and mass effect with displacement of the first and second portions of the duodenum without luminal obstruction or mural invasion, associated with prominent gastroduodenal veins and early portal vein opacification. Based on the lesion's location and enhancement pattern, the initial radiologic impression was that of a pancreatic neuroendocrine tumor (NET). At laparotomy, the procedure was aborted because of severe intraoperative hemorrhage related to tumor hypervascularity, and only an incisional biopsy was obtained. Histopathology showed a mesenchymal neoplasm with a mixed spindle-cell and epithelioid pattern arranged in intersecting fascicles without necrosis. Immunohistochemistry demonstrated strong, diffuse DOG1 expression and negativity for epithelial, muscular, endothelial, and neural markers, with a Ki-67 index of approximately 1%, consistent with a low-risk gastrointestinal stromal tumor (GIST). After multidisciplinary discussion, pancreaticoduodenectomy and tyrosine kinase inhibitor therapy were proposed, but the patient declined and has been managed conservatively with close follow-up and symptomatic improvement. In this patient, the pancreatic mass mimicked a NET on imaging and was ultimately identified as an extragastrointestinal stromal tumor (GIST), underscoring the importance of histopathologic and immunohistochemical confirmation when evaluating hypervascular pancreatic lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.